Back to All News

Accuray Incorporated (ARAY) - Initiation of Research Coverage

November 30, 2017

Lake Street Capital Markets Analyst Brooks O’Neil initiated coverage of Accuray Incorporated (ARAY), with a BUY rating and price target of $10 (ARAY, $5.20). Accuray designs, manufactures and sells machines that deliver precise radiation treatments with the aim of helping patients with cancer live longer, better lives. Their products include the CyberKnife Systems, TomoTherapy Systems and Radixact Delivery Treatment Platform.

Contact Us


US Mail
920 Second Avenue South
Suite 700
Minneapolis, MN 55402

Email Us

Find Us